An update from Pascal Biosciences Inc ( (TSE:NEVI) ) is now available.
Nevis Brands Inc reported a significant 61% increase in revenue for Q1 2025, reaching $416,355, with a gross profit of $323,722 and net income of $60,430. The company attributes this growth to expanding its presence in New Jersey and Missouri while maintaining strong sales in Washington. Nevis is optimistic about its new hemp-derived THC product, Happy Apple, and plans to enter new markets in Q2 2025, indicating a positive outlook for continued growth and market expansion.
Spark’s Take on TSE:NEVI Stock
According to Spark, TipRanks’ AI Analyst, TSE:NEVI is a Neutral.
Nevis Brands Inc demonstrates strong revenue growth and strategic expansions, suggesting potential for future success. However, ongoing profitability and cash flow issues significantly impact its financial health. The bearish technical indicators and challenging valuation metrics further weigh down the stock’s attractiveness. While positive corporate events offer optimism, the company must overcome its financial hurdles to improve its stock performance.
To see Spark’s full report on TSE:NEVI stock, click here.
More about Pascal Biosciences Inc
Nevis Brands Inc is a leading provider of cannabis beverage brands, known for innovating and developing products consumed by millions across various states including Washington, Oregon, California, Colorado, Arizona, Nevada, and Ohio. The company partners with leading cannabis product manufacturers and distributors to enhance their offerings and is publicly traded on the CSE, OTCQB, and Frankfurt Stock Exchange.
YTD Price Performance: -55.00%
Average Trading Volume: 35,172
Technical Sentiment Signal: Buy
Current Market Cap: C$1.98M
Learn more about NEVI stock on TipRanks’ Stock Analysis page.